CS
ZIVO

Credit Suisse’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Credit Suisse’s Portfolio ZIVO Stock Details ZIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,522
Closed -$206K – 4713
2021
Q3 		$206K Buy
+7,522
New +$165K ﹤0.01% 4224

Other funds holding ZIVO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Credit Suisse's ZIVO Position: Q4 2021 in Review

Credit Suisse sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2021, closing a stake of 7,522 shares — an estimated $206K sold.

Credit Suisse first reported a position in ZIVO in Q3 2021 and held it in 1 quarter. The position peaked at $206K in Q3 2021. 12 funds tracked by Wall St. Rank hold ZIVO as of Q4 2021.

  • Credit Suisse reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Credit Suisse sold 7,522 Zivo Bioscience, Inc. Common Stock shares in Q4 2021, an estimated $206K.
  • Credit Suisse first reported a position in Zivo Bioscience, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Credit Suisse's Zivo Bioscience, Inc. Common Stock position peaked at $206K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.